FDA Drug Application (206137) for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE by PAR PHARM INC

Back to FDA Applications sponsored by PAR PHARM INC

Application Number206137
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;12.5MG;20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
Active IngredientAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient OLMESARTAN MEDOXOMIL11


Back to FDA Applications sponsored by PAR PHARM INC